Literature DB >> 18594844

Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.

Shunsuke Tsukamoto1, Shin Fujita, Tomohiro Yamaguchi, Seiichiro Yamamoto, Takayuki Akasu, Yoshihiro Moriya, Hirokazu Taniguchi, Tadakazu Shimoda.   

Abstract

BACKGROUND: To clarify the oncological outcome of rectal well-differentiated neuroendocrine tumors (W/D NETs), we examined the clinicopathological characteristics and prognosis of patients with this neoplasm.
MATERIALS AND METHODS: A total of 23 patients who underwent surgical treatment with lymph node dissection for rectal W/D NETs between 1973 and 2007 were reviewed.
RESULTS: Median tumor size measured preoperatively was 13 mm (range, 4-25 mm), and the median number of dissected lymph nodes was 16 (range, 1-46). The incidence of lymph node metastasis was 61% (14 of 23 cases). The smallest W/D NETs with lymph node metastasis was 10 mm in diameter. All the patients without lymph node metastasis survived without recurrence. Among 11 patients who had only regional lymph node metastasis, only one developed liver metastasis and died 13 months after initial surgery. Among three patients with lateral pelvic lymph node metastasis, two survived more than 5 years, although two had liver metastasis.
CONCLUSIONS: Because the incidence of lymph node metastasis is very high in patients with rectal W/D NETs greater than 10 mm in diameter, radical surgery is required. In this series, the outcome of rectal W/D NETs patients with lateral pelvic lymph node metastasis was better than expected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594844     DOI: 10.1007/s00384-008-0505-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

Review 3.  Current status of gastrointestinal carcinoids.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Michael D Shapiro
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

4.  Prediction of lateral pelvic node involvement in low rectal cancer by conventional computed tomography.

Authors:  H Yano; Y Saito; E Takeshita; O Miyake; N Ishizuka
Journal:  Br J Surg       Date:  2007-08       Impact factor: 6.939

Review 5.  Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.

Authors:  G Rindi; V Villanacci; A Ubiali
Journal:  Digestion       Date:  2000       Impact factor: 3.216

Review 6.  Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.

Authors:  Jun Soga
Journal:  Cancer       Date:  2005-04-15       Impact factor: 6.860

Review 7.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

Review 8.  Potency, cure, and local control in the operative treatment of rectal cancer.

Authors:  W E Enker
Journal:  Arch Surg       Date:  1992-12

9.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

10.  Lateral pelvic lymph node dissection for advanced lower rectal cancer.

Authors:  S Fujita; S Yamamoto; T Akasu; Y Moriya
Journal:  Br J Surg       Date:  2003-12       Impact factor: 6.939

View more
  10 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

2.  Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors.

Authors:  Wei-Jie Chen; Nan Wu; Jiao-Lin Zhou; Guo-Le Lin; Hui-Zhong Qiu
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  Endoscopic resection for rectal carcinoid tumors: comparison of polypectomy and endoscopic submucosal resection with band ligation.

Authors:  Sang Heon Lee; Seun Ja Park; Hyung Hun Kim; Kyung Sun Ok; Ji Hyun Kim; Sam Ryong Jee; Sang Young Seol; Bo Mi Kim
Journal:  Clin Endosc       Date:  2012-03-31

4.  Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.

Authors:  Peng Li; Fan Wu; Hong Zhao; Lizhou Dou; Yang Wang; Chunguang Guo; Guiqi Wang; Dongbing Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 5.  [Neuroendocrine neoplasms of the appendix and colorectum].

Authors:  G Klöppel; H Scherübl
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

6.  The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.

Authors:  Shinya Sugimoto; Kinichi Hotta; Tadakazu Shimoda; Kenichiro Imai; Yuichiro Yamaguchi; Takashi Nakajima; Takuma Oishi; Keita Mori; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2015-12-30       Impact factor: 4.584

Review 7.  Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis.

Authors:  Xin Zhou; Haiting Xie; Lingduo Xie; Jing Li; Wei Fu
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

8.  Rectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion.

Authors:  Kohei Nagata; Kazuto Tajiri; Seitarou Shimada; Takayuki Ando; Ayumu Hosokawa; Koshi Matsui; Joji Imura; Toshiro Sugiyama
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

9.  Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours.

Authors:  Xiuli Zheng; Mingli Wu; Limian Er; Huiyan Deng; Gongning Wang; Lingyao Jin; Shengmian Li
Journal:  Int J Colorectal Dis       Date:  2022-01-08       Impact factor: 2.571

10.  A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report.

Authors:  Manabu Inoue; Shunsuke Tsukamoto; Konosuke Moritani; Hideki Sekine; Yutaka Saito; Yukihide Kanemitsu
Journal:  Int J Surg Case Rep       Date:  2022-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.